Ivey Business School (Canada)
-
Investing in a Unicorn: The Case of Luckin Coffee Gone Rogue
Andrea Santiago; Fernando Martin Roxas; Maria Theresa ManalacCase IVEY-9B21N001-EFinanceLuckin Coffee Inc. (Luckin), an emerging growth firm that aimed to become the market leader in the coffee industry in China, had quickly grabbed market share by using freebies and discounts to entice cost-conscious Chinese consumers to try its products. Luckin sold its coffee and snacks through a proprietary mobile app, and customers either picked up their orders from strategically located stores or had them delivered. By the end of 2019, Luckin ...Starting at €8.20
-
The RealReal Inc.: Fashion Fad or Long-Term Investment
Shernaz Bodhanwala; Ruzbeh BodhanwalaCase IVEY-9B20N035-EEntrepreneurship, Finance, StrategyThe RealReal Inc. (Real), a San Francisco, California-based start-up engaged in the trade of used luxury goods, experienced significant growth in its revenue and customer base in fiscal year (FY) 2018, but it was yet to turn profitable after nine years inStarting at €8.20
-
Turing Pharmaceuticals: The Ethics of Drug Pricing
Shernaz Bodhanwala; Aakash BothraCase IVEY-9B17M167-EStrategyIn 2015 there was a public outcry over the price increase in Daraprim (pyrimethamine) by Turing Pharmaceuticals AG (Turing). Daraprim was a drug that was widely used by a small population of U.S. patients to treat toxoplasmosis. Soon after Turing acquired its commercialization rights in August 2015, the company increased the list price of the drug by over 5,000 per cent. The increase led to consumer protests in the United States, and the media ve...Starting at €8.20